A case of BNT162b2 COVID-19 vaccine-associated fulminant myocarditis in a very elderly woman

Kaishi Otsuka; Takashi Matsuo; Takashi Ishimatsu; Atsuki Fukae; Takuro Hamamoto; Koji Oku; Masahiro Ito

doi:10.1002/ccr3.6161

A case of BNT162b2 COVID-19 vaccine-associated fulminant myocarditis in a very elderly woman

Clin Case Rep. 2022 Sep 5;10(9):e6161. doi: 10.1002/ccr3.6161. eCollection 2022 Sep.

Authors

Kaishi Otsuka¹, Takashi Matsuo¹, Takashi Ishimatsu¹, Atsuki Fukae¹, Takuro Hamamoto¹, Koji Oku¹, Masahiro Ito¹

Affiliation

¹ National Hospital Organization Nagasaki Medical Center Nagasaki Japan.

Abstract

Coronavirus disease 2019 (COVID-19) vaccination is reportedly safe and effective. The histologic features of post-COVID-19 vaccination myocarditis are unknown. We present a case of a 77-year-old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the second dose of BNT162b2 COVID-19 vaccine. Steroid pulse therapy was effective.

Keywords: COVID‐19; cardiogenic shock; heart failure; myocarditis.

Publication types

Case Reports